Trial Profile
Compare with methotrexate tablets to evaluate the randomized double-blind, multicenter clinical trial to trial the efficacy and safety of the injection technetium 99Tc methylene diphosphonate treatment for active rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2021
Price :
$35
*
At a glance
- Drugs Tc 99m oxidronic acid (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 19 May 2021 Primary endpoint (ACR20) has been met, as per results published in the Chinese Medical Journal.
- 19 May 2021 Results assessing efficacy and safety of 99Tc-MDP in rheumatoid arthritis treatment, published in the Chinese Medical Journal.
- 29 Apr 2016 New trial record